All sponsors

DualityBio Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS10
PHASE 3 / 2-32
RECRUITING7
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO78%

Delay Index: of 9 active trials registered more than a year ago, 7 have moved their primary completion (readout) date by more than 6 months since first registration (median +16.0 months). See all sponsors →

Open DualityBio Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
DB-1303/BNT323
NCT06018337
P3Active, not recruitingMetastatic Breast Cancer5412026-08-12 (+12 mo)
DB-1419
NCT06554795
P1/2RecruitingSolid Tumor, Adult3602027-02
DB-2304
NCT06625671
P1/2RecruitingSystemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus1482027-06-30 (+15 mo)
DB-1303/BNT323
NCT05150691
P1/2RecruitingHER2-positive Advanced Solid Tumor7962027-08 (+26 mo)
DB-1305/BNT325
NCT05438329
P1/2Active, not recruitingAdvanced Solid Tumor11232027-08-13 (+25 mo)
DB-1311
NCT05914116
P1/2RecruitingAdvanced Solid Tumors8622027-12 (+32 mo)
DB-1303/BNT323
NCT06265428
P3Active, not recruitingHER2-positive Breast Cancer2282027-12 (+22 mo)
DB-1310
NCT05785741
P1/2RecruitingAdvanced Solid Tumor10002027-12-30 (+16 mo)
DB-1324
NCT07263594
P1/2RecruitingGastrointestinal Cancer1272028-12
DB-1311/BNT324
NCT06953089
P2RecruitingSolid Tumors7502030-06-30